Impact of first-line cryoablation for atrial fibrillation on healthcare utilization, arrhythmia disease burden and efficacy outcomes: real-world evidence from the Cryo Global Registry

  • Zucchelli, Giulio; 
  • Chun, K. R. Julian; 
  • Khelae, Surinder Kaur; 
  • Foldesi, Csaba; 
  • Kueffer, Fred J.; 
  • ... On, Young-Keun; 
  • 외 4명
Citations

WEB OF SCIENCE

7
Citations

SCOPUS

8

초록

Background Cryoballoon ablation (CBA) is an effective first-line treatment for symptomatic atrial fibrillation (AF), as recently demonstrated by three randomized trials. This sub-analysis of the Cryo Global Registry aims to examine current clinical practices of first-line CBA. Methods AF patients treated with first-line CBA were compared to CBA in antiarrhythmic drug (AAD)-refractory patients at 12 months. Efficacy was examined using time-to-first atrial arrhythmia recurrence following a 90-day blanking period. Healthcare utilization was evaluated by repeat ablations and hospitalizations. Disease burden was examined by assessing quality of life (QOL) and patients' reporting of symptoms. Results Of 1394 patients, 433 (31.1%) were treated with first-line CBA, which was more frequent in high-volume centers. Serious procedure-related adverse event rates were similar. Efficacy at 12 months was higher in the first-line group (87.8 vs. 81.6%, HRunadj 0.64 (95% CI 0.47-0.88); p < 0.01) regardless of the centers' CBA experience; when controlling for baseline characteristics, the difference was not significant (HRadj 0.87 (95% CI 0.56-1.37); p = 0.55). No difference was observed in repeat ablations and hospitalizations between cohorts. First-line patients experienced a larger mean reduction in symptoms and were prescribed AADs at a lower rate at 12-month follow-up (9.7 vs. 29.9%). QOL improved in both cohorts from baseline to 12 months with no significant difference between groups (p = 0.29). Conclusions In this global real-world experience, first-line CBA in patients with symptomatic AF is effective, with a larger symptom reduction compared with CBA after AAD failure and without a difference in healthcare utilization at mid-term follow-up.

키워드

Atrial fibrillation; Catheter ablation; Cryoballoon; First-line ablation; Registry; RADIOFREQUENCY ABLATION; ANTIARRHYTHMIC-DRUGS; CATHETER ABLATION; CRYOBALLOON; PREDICTORS; THERAPY; PROGRESSION; RECURRENCE
제목
Impact of first-line cryoablation for atrial fibrillation on healthcare utilization, arrhythmia disease burden and efficacy outcomes: real-world evidence from the Cryo Global Registry
저자
Zucchelli, Giulio; Chun, K. R. Julian; Khelae, Surinder Kaur; Foldesi, Csaba; Kueffer, Fred J.; van Bragt, Kelly A.; Scazzuso, Fernando; On, Young-Keun; Al-Kandari, Fawzia; Okumura, Ken
DOI
10.1007/s10840-022-01388-6
발행일
2023-04
유형
Article
저널명
Journal of Interventional Cardiac Electrophysiology
권
66
호
3
페이지
711 ~ 722